Inhibition by tranilast of vascular endothelial growth factor (VEGF) vascular permeability factor (VPF)-induced increase in vascular permeability in rats

被引:16
作者
Isaji, M
Miyata, H
Ajisawa, Y
Yoshimura, N
机构
[1] Kissei Pharmaceut Co Ltd, Discovery Res Labs, Minamiazumi, Nagano 39983, Japan
[2] Shinshu Univ, Sch Med, Dept Ophthalmol, Matsumoto, Nagano 390, Japan
关键词
tranilast; VEGF/VPF; vascular permeability; edema; air pouch;
D O I
10.1016/S0024-3205(98)00277-X
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We studied the effects of tranilast, an anti-allergic and anti-proliferative drug in clinical use, on VEGF/VPF-induced vascular permeability in a rat air pouch model. A large increase in vascular permeability was induced by injection of 4 ml of a 100 ng/ml VEGF/VPF solution into the preformed air pouch. Over a 15-min period, tranilast inhibited the VEGF/VPF-induced vascular permeability in a dose-dependent manner. This result suggests that tranilast, which we recently found to inhibit VEGF/VPF-induced angiogenesis, could also improve VEGF/VPF-dependent increases in vascular permeability. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:PL71 / PL74
页数:4
相关论文
共 19 条
[1]   Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor [J].
Aiello, LP ;
Bursell, SE ;
Clermont, A ;
Duh, E ;
Ishii, H ;
Takagi, C ;
Mori, F ;
Ciulla, TA ;
Ways, K ;
Jirousek, M ;
Smith, LEH ;
King, GL .
DIABETES, 1997, 46 (09) :1473-1480
[2]   PHARMACOLOGICAL PROPERTIES OF N-(3',4'-DIMETHOXYCINNAMOYL) ANTHRANILIC ACID (N-5'), A NEW ANTI-ATOPIC AGENT [J].
AZUMA, H ;
BANNO, K ;
YOSHIMURA, T .
BRITISH JOURNAL OF PHARMACOLOGY, 1976, 58 (04) :483-488
[3]   CHARACTERIZATION OF THE INCREASE IN VASCULAR-PERMEABILITY INDUCED BY VASCULAR-PERMEABILITY FACTOR INVIVO [J].
COLLINS, PD ;
CONNOLLY, DT ;
WILLIAMS, TJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 109 (01) :195-199
[4]  
EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205
[5]   The biology of vascular endothelial growth factor [J].
Ferrara, N ;
DavisSmyth, T .
ENDOCRINE REVIEWS, 1997, 18 (01) :4-25
[6]   ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE [J].
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (01) :27-31
[7]   HISTOPATHOLOGY OF DIABETIC-RETINOPATHY IN MAN [J].
GARNER, A .
EYE, 1993, 7 :250-253
[8]   Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression [J].
Goldman, CK ;
Bharara, S ;
Palmer, CA ;
Vitek, J ;
Tsai, JC ;
Weiss, HL ;
Gillespie, GY .
NEUROSURGERY, 1997, 40 (06) :1269-1277
[9]  
GOTO Y, 1991, CLIN REPORT, V25, P69
[10]   Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo [J].
Isaji, M ;
Miyata, H ;
Ajisawa, Y ;
Takehana, Y ;
Yoshimura, N .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (06) :1061-1066